Pegasys (peginterferon alfa-2a) is a pegylated form of interferon therapy used in treating certain types of leukemia. While the pegylated formula was designed to stay in the blood longer and reduce side effects compared to older interferon versions, liver toxicity is a serious concern that warrants close attention.
Show Full Answer
Pegasys (peginterferon alfa-2a) is a pegylated form of interferon therapy used in treating certain types of leukemia. While the pegylated formula was designed to stay in the blood longer and reduce side effects compared to older interferon versions, liver toxicity is a serious concern that warrants close attention.
Liver-related side effects with Pegasys can include elevated liver enzymes and, in more severe cases, liver damage. This is why regular blood tests and monitoring by your doctor are especially important while on this treatment.
Some general side effects to watch for that may signal liver stress include:
- Nausea or vomiting
- Abdominal pain
- Unusual fatigue or dizziness
- Jaundice (yellowing of skin or eyes)
In rare but serious cases, interferon therapy has been linked to more severe complications including kidney damage and other organ-related issues, so it's critical to report any worsening symptoms to your healthcare team right away.
The 135 mcg dose is a reduced dose (the standard is 180 mcg), which may be prescribed to help manage tolerability. If liver toxicity is a concern at your current dose, your doctor may consider adjusting it further or exploring alternative treatments.
Always keep your care team informed about any new or worsening symptoms — they can run liver function tests to monitor what's happening and act quickly if needed.
AI-generated responses are not a substitute for medical advice. These services are not intended to
diagnose, treat, or cure any condition or disease. Always ask your doctor about specific health concerns.
Interferon Therapy for Leukemia: When Is It Used?
May 4
Join
Your Privacy Choices
